Table 1.
Summary statistics of some important baseline characteristics using all 1752 2-year cycles coming from 935 unique patients in SMSC
| Characteristics | Number of observations (n = 1752) |
|---|---|
| Relapse within 2 years | |
| Yes | |
| n (%) | 302 (17.2) |
| No | |
| n (%) | 1450 (82.8) |
| Gender | |
| Females | |
| n (%) | 1209 (69) |
| Males | |
| n (%) | 543 (31) |
| Currently on treatment | |
| Yes | |
| n (%) | 1639 (93.6) |
| No | |
| n (%) | 113 (6.4) |
| NA | |
| n (%) | 34 (2.0) |
| Age | |
| mean ± sd | 42.4 ± 11.3 |
| min | 18 |
| max | 76.4 |
| Disease duration (years) | |
| mean ± sd | 10.9 ± 8.3 |
| min | 0.0 |
| max | 41.2 |
| EDSS | |
| mean ± sd | 2.4 ± 1.4 |
| min | 0.0 |
| max | 7.0 |
| Number of gadolinium-enhanced lesions | |
| = 0 | |
| n (%) | 956 (55.0) |
| = 1 | |
| n (%) | 26 (1.0) |
| ≥ 2 | |
| n (%) | 25 (1.0) |
| NA | |
| n (%) | 745 (43.0) |